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E J C S U P P L E M E N T S 4 ( 2 0 0 6 ) 2 7 –5 3 39isolated from freshly resected gliomas grade II, III and IV (each
n = 3) using a modified magnetic bead protocol. Differentiation
of cultured cells was assessed immunohistochemically using
anti-GFAP, -NSE, -CD31, -CD105, -VE cadherin, Musashi-1 and
AC133/1+2.
Results: CD133 positive cells could be detected in 7/10 gliomas
WHO II, 8/10 gliomas WHOIII and 9/10 GBM. These cells were
found arranged in clusters, mostly associated to intratumoral
vessels, rarely located diffusely within the tumor parenchyma.
CD133 expression correlated with WHO grade: 1–5% of cells in gli-
omas WHO II, 5–10% of cells in gliomas WHO III, and 10–15% of
cells in GBM stained positive for CD133. Western-blot analysis
confirmed the correlation with tumor grade. CD133+ cells that
have been isolated from specimens of all tumor grades stained
positive for Musashi-1. Under different culture conditions, rapid
proliferation of CD133+ cells occurred. After several passages,
cells lost CD133 expression and became positive for GFAP, NSE
or CD31/CD105/VE cadherin.
Conclusions: This study represents the first documentation for
the presence of pluripotent, highly proliferative CD133+ CSC in
low grade gliomas, which are able to differentiate into cells
expressing glial, neuronal or endothelial markers. The presence
of CSC in high grade gliomas could be confirmed, showing a
higher proportion than in low grade gliomas. The role of these
cells during stepwise glioma progression still has to be evaluated.
doi:10.1016/j.ejcsup.2006.04.092
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Background: Here we show that the expression of avb3, a puta-
tive key player of angiogenesis in malignant glioma may be less
pronounced in brain derived glial tumors as supposed by former
studies and is not restricted to activated endothelial cells.
Methods: Cryosections of histopathologically confirmed high
(n = 25) and low (n = 10) grade gliomas, were immunostained for
detection of avb3-expression. Microvascular density of the sam-
ples was determined by co-staining with endothelial cell specific
markers (CD31, CD105). Moreover Western blot analysis of con-
secutive cryosections was performed to further investigate the
relative vascularisation and integrin expression in these tumors.
Results: Immunohistochemistry confirmed that high grade glio-
mas not only show a higher rate of avb3-positive proliferating
endothelial cells but have a higher number of avb3-expressing
tumor cells compared to low grade gliomas. Western blot analysis
revealed that avb3-expression in malignant gliomas was higher
as seen in low grade gliomas. Interestingly all glial tumors
showed less integrin expression and less avb3-positive endothe-
lial cells compared to solid non-CNS tumors. In return the rate
of integrin-positive tumor cells was higher in all gliomas com-
pared to the peripheral tumors.Conclusion: Expression of avb3 integrin is lower in glial tumors
compared with most peripheral solid tumors. In gliomas the frac-
tion of tumor cells expressing avb3 is higher as in non-CNS
tumors. Therefore the function of this integrin in brain derived
tumors may not be restricted to angiogenesis alone and new anti-
angiogenic drugs targeting this integrin may have control over the
tumor cells themselves.
doi:10.1016/j.ejcsup.2006.04.093
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Background: Glioblastomas (WHO grade IV) are highly vascular-
ised brain tumours. Targeting glioma angiogenesis several studies
aim at the VEGF/VEGFR2 system, however, the presence and role
of VEGFR3 in gliomas has not been investigated elaborately up to
date. Here we show the high expression of VEGFR3 and its ligands
in gliomas correlating with tumour grade.
Method: Human brain tumours WHO grade II (n = 8), grade IV
(n = 20) and non neoplastic brain (n = 3) were investigated for
expression of VEGFR-3, VEGF-C and VEGF-D on mRNA and protein
level by use of real-time PCR, immunohistochemistry and Wes-
tern blot analysis.
Results: Expression of VEGFR-3, VEGF-C and VEGF-D was very
high in glioblastomas, scant in grade II gliomas and absent in
non neoplastic brain. These findings were confirmed by Western
blot. VEGFR-3 in glioblastomas was mainly present on tumor
endothelium. VEGF-C and -D were expressed strongest in areas
of high vessel density. On mRNA level, transcripts for all proteins
were significantly elevated in glioblastomas compared to grade II
gliomas and non neoplastic brain.
Conclusion: VEGFR3 expression correlates with tumour grade
showing highest levels in glioblastomas. With also the receptor
ligands VEGF-C and -D being strongly expressed, these findings
reveal the presence of an alternative angiogenic signalling system
in these tumours. This may influence the paradigm of glioma
angiogenesis and may lead to more effective anti-angiogenic
treatment strategies.
doi:10.1016/j.ejcsup.2006.04.094
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